Advertisement
Screener

FULCRUM THERAPEUTICS, INC. (FULC) Net Margin

FULCRUM THERAPEUTICS, INC. (FULC) Net Margin

  • 2024-06-30: Net Margin 69.26%.
  • 2023-12-31: Net Margin -2842.25%.
  • 2023-09-30: Net Margin -3164.30%.
  • 2023-06-30: Net Margin -2702.61%.

Complete source-backed net margin history.

Available history
2020-03-31 to 2024-12-31
Data captured

Historical Net Margin

DateNet Margin
2024-06-3069.26%
2023-12-31-2842.25%
2023-09-30-3164.30%
2023-06-30-2702.61%
2023-03-31-8399.66%
2022-12-31-3815.33%
2022-09-30-2006.59%
2022-06-30-1810.31%
2022-03-31-1000.31%
2021-12-31-206.67%
2021-09-30-419.78%
2021-06-30-448.48%
2021-03-31-354.96%
2020-12-31-419.41%
2020-09-30-1026.08%
2020-06-30-784.25%
2020-03-31-2460.27%

Annual Net Margin

DateNet Margin
2024-12-31-12.16%
2023-12-31-3470.05%
2022-12-31-1732.43%
2021-12-31-421.89%
2020-12-31-802.66%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Contineum Therapeutics, Inc. (CTNM)United States$0.289B-4.40
Perspective Therapeutics, Inc. (CATX)United States$0.284B-3.34
Upstream Bio, Inc. (UPB)United States$0.284B-2.42
ROCKET PHARMACEUTICALS, INC. (RCKT)United States$0.296B-21.78
STANDARD BIOTOOLS INC. (LAB)United States$0.297B3.80
Sagimet Biosciences Inc. (SGMT)United States$0.279B
Vanda Pharmaceuticals Inc. (VNDA)United States$0.302B-1.35
GT Biopharma, Inc. (GTBP)United States$0.309B-4.58
Mereo BioPharma Group plc (MREO)$0.269B-9.41
Greenwich LifeSciences, Inc. (GLSI)United States$0.267B-15.02